Health-related quality of life in patients with advanced metastatic melanoma: results of a randomized phase III study comparing temozolomide with dacarbazine. [electronic resource]
Producer: 20040204Description: 821-9 p. digitalISSN:- 0735-7907
- Administration, Oral
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Alkylating -- adverse effects
- Cognition
- Dacarbazine -- adverse effects
- Emotions
- Female
- Health Status
- Humans
- Infusions, Intravenous
- Male
- Melanoma -- drug therapy
- Middle Aged
- Quality of Life
- Skin Neoplasms -- drug therapy
- Sleep
- Survival Analysis
- Temozolomide
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.